-
1Academic Journal
Authors: N. V. Danilova, V. M. Kkomyakov, A. V. Chayka, I. A. Mikhailov, N. A. Oleynikova, P. G. Malkov, Н. В. Данилова, В. М. Хомяков, А. В. Чайка, И. А. Михайлов, Н. А. Олейникова, П. Г. Мальков
Contributors: This research was carried out as part of the state assignment of Lomonosov Moscow State University, Работа выполнена в рамках госзадания ФГБОУ ВО «МГУ им. М.В. Ломоносова».
Source: Siberian journal of oncology; Том 20, № 1 (2021); 74-86 ; Сибирский онкологический журнал; Том 20, № 1 (2021); 74-86 ; 2312-3168 ; 1814-4861 ; 10.21294/1814-4861-2021-20-1
Subject Terms: прогностические факторы, tumor microenvironment, morphometric analysis, immunohistochemistry, CD8-positive T-lymphocytes, survival analysis, prognostic factors, иммунное микроокружение, морфометрический анализ, иммуногистохимия, cd8-позитивные t-лимфоциты, анализ выживаемости
File Description: application/pdf
Relation: https://www.siboncoj.ru/jour/article/view/1694/830; Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov; 68(6): 394–424. doi:10.3322/caac.21492.; Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11; 513(7517): 202–9. doi:10.1038/nature13480.; Ajani J.A., Amin M.B., Edge S., Greene F., Byrd D.R., Brookland R.K. AJCC Cancer Staging Manual. 8th ed. Springer, American Joint Committee on Cancer; 2017. 1032 p.; Jiang W., Liu K., Guo Q., Cheng J., Shen L., Cao Y., Wu J., Shi J., Cao H., Liu B., Tao K., Wang G., Cai K. Tumor-infiltrating immune cells and prognosis in gastric cancer: a systematic review and meta-analysis. Oncotarget. 2017 May 3; 8(37): 62312–62329. doi:10.18632/oncotarget.17602.; Zhang D., He W., Wu C., Tan Y., He Y., Xu B., Chen L., Li Q., Jiang J. Scoring System for Tumor-Infiltrating Lymphocytes and Its Prognostic Value for Gastric Cancer. Front Immunol. 2019; 10: 71. doi:10.3389/fimmu.2019.00071.; Kumar V., Abbas A.K., Aster J.C. Robbins and Cotran Pathologic Basis of Disease. Philadelphia: Elsevier Saunders. 2015.; Lu P., Weaver V.M., Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012; 196(4): 395–406. doi:10.1083/jcb.201102147.; Fridman W.H., Pagès F., Sautès-Fridman C., Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012 Mar 15; 12(4): 298–306. doi:10.1038/nrc3245. PMID: 22419253.; Ma H.Y., Liu X.Z., Liang C.M. Inflammatory microenvironment contributes to epithelial-mesenchymal transition in gastric cancer. World J Gastroenterol. 2016 Aug 7; 22(29): 6619–28. doi:10.3748/wjg.v22.i29.6619.; Sawayama H., Ishimoto T., Baba H. Microenvironment in the pathogenesis of gastric cancer metastasis. J Cancer Metastasis Treat. 2018; 4(10). doi:10.20517/2394-4722.2017.79.; Liu K., Yang K., Wu B., Chen H., Chen X., Chen X., Jiang L., Ye F., He D., Lu Z., Xue L., Zhang W., Li Q., Zhou Z., Mo X., Hu J.Tumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer. Medicine (Baltimore). 2015 Sep; 94(39): e1631. doi:10.1097/MD.0000000000001631.; Hendry S., Salgado R., Gevaert T., Russell P.A., John T., Thapa B., Christie M., van de Vijver K., Estrada M.V., Gonzalez-Ericsson P.I., Sanders M., Solomon B., Solinas C., Van den Eynden G.G.G.M., Allory Y., Preusser M., Hainfellner J., Pruneri G., Vingiani A., Demaria S., Symmans F., Nuciforo P., Comerma L., Thompson E.A., Lakhani S., Kim S.-R., Schnitt S., Colpaert C., Sotiriou C., Scherer S.J., Ignatiadis M., Badve S., Pierce R.H., Viale G., Sirtaine N., Penault-Llorca F., Sugie T., Fineberg S., Paik S., Srinivasan A., Richardson A., Wang Y., Chmielik E., Brock J., Johnson D.B., Balko J., Wienert S., Bossuyt V., Michiels S., Ternes N., Burchardi N., Luen S.J., Savas P., Klauschen F., Watson P.H., Nelson B.H., Criscitiello C., O’Toole S., Larsimont D., de Wind R., Curigliano G., Andre F., Lacroix-Triki M., van de Vijver M., Rojo F., Floris G., Bedri S., Sparano J., Rimm D., Nielsen T., Kos Z., Hewitt S., Singh B., Farshid G., Loibl S., Allison K.H., Tung N., Adams S., Willard-Gallo K., Horlings H.M., Gandhi L., Moreira A., Hirsch F., Dieci M.V., Urbanowicz M., Brcic I., Korski K., Gaire F., Koeppen H., Lo A., Giltnane J., Rebelatto M.C., Steele K.E., Zha J., Emancipator K., Juco J.W., Denkert C., Reis-Filho J. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invas. Adv Anat Pathol. 2017 Sep; 24(5): 235–251. doi:10.1097/PAP.0000000000000162.; Mikhailov I., Danilova N., Malkov P., Oleynikova N. CD4+ and CD8+ lymphocytes in the immune microenvironment of gastric cancer: evaluation in Tumour Tissue (TT) and Adjacent Areas of Unchanged Mucosa (AAUM). Virchows Arch. 2019; 475(Suppl 1): S282. doi:10.1007/s00428-019-02631-8.; Löffek S., Zigrino P., Angel P., Anwald B., Krieg T., Mauch C. High invasive melanoma cells induce matrix metalloproteinase-1 synthesis in fibroblasts by interleukin-1alpha and basic fibroblast growth factormediated mechanisms. J Invest Dermatol. 2005 Mar; 124(3): 638–43. doi:10.1111/j.0022-202X.2005.23629.x.; Wang Y., Wu H., Wu X., Bian Z., Gao Q. Interleukin 17A promotes gastric cancer invasiveness via NF-κB mediated matrix metalloproteinases 2 and 9 expression. PLoS One. 2014; 9(6): e96678. doi:10.1371/journal.pone.0096678.; https://www.siboncoj.ru/jour/article/view/1694